• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从体外数据得出的关于体内活性的结论。

Conclusion to be derived from in vitro data with respect to in vivo activity.

作者信息

Gotoh S

出版信息

Clin Ther. 1981;4 Suppl A:8-17.

PMID:7326694
Abstract

Cefazolin and gentamicin were administered to mice with polymicrobial infection by Escherichia coli and Pseudomonas aeruginosa. Changes in the quantities of these bacteria in blood were investigated. Bacterial replacement was evident. Cefazolin was administered to mice with polymicrobial infection by E. coli and Bacteroides fragilis. Cefazolin was inactivated by B. fragilis-produced beta-lactamases. It was confirmed that the quantities of both B. fragilis and E. coli in blood increased. Even broad-spectrum antibiotics have different antibacterial activity against various bacteria. The present study suggested that an appropriate administration schedule should be determined to first inhibit the growth of a highly resistant bacterium in polymicrobial infection. It was also suggested that an antibiotic that can inhibit the growth of a more resistant bacterium should first be administered in polymicrobial infection. In vivo antibacterial activity of broad-spectrum antibiotics should be separately evaluated in mono-microbial infection and polymicrobial infection.

摘要

将头孢唑林和庆大霉素给予由大肠杆菌和铜绿假单胞菌引起的多微生物感染的小鼠。研究了这些细菌在血液中的数量变化。细菌替代现象明显。将头孢唑林给予由大肠杆菌和脆弱拟杆菌引起的多微生物感染的小鼠。头孢唑林被脆弱拟杆菌产生的β-内酰胺酶灭活。已证实血液中脆弱拟杆菌和大肠杆菌的数量均增加。即使是广谱抗生素对不同细菌也有不同的抗菌活性。本研究表明,应确定适当的给药方案,首先抑制多微生物感染中高度耐药细菌的生长。还表明,在多微生物感染中应首先给予能抑制更耐药细菌生长的抗生素。广谱抗生素的体内抗菌活性应在单微生物感染和多微生物感染中分别进行评估。

相似文献

1
Conclusion to be derived from in vitro data with respect to in vivo activity.从体外数据得出的关于体内活性的结论。
Clin Ther. 1981;4 Suppl A:8-17.
2
Antibiotic use in neonatal sepsis.新生儿败血症中的抗生素使用。
Turk J Pediatr. 1998 Jan-Mar;40(1):17-33.
3
The use of intradiscal antibiotics for discography: an in vitro study of gentamicin, cefazolin, and clindamycin.椎间盘造影术中椎间盘内抗生素的应用:庆大霉素、头孢唑林和克林霉素的体外研究
Spine (Phila Pa 1976). 2003 Aug 1;28(15):1735-8. doi: 10.1097/01.BRS.0000087301.71177.85.
4
Antibacterial activity of cefquinome against equine bacterial pathogens.头孢喹肟对马属动物细菌病原体的抗菌活性。
Vet Microbiol. 2006 Jun 15;115(1-3):140-7. doi: 10.1016/j.vetmic.2005.12.019. Epub 2006 Feb 7.
5
In vitro activity of ertapenem: review of recent studies.厄他培南的体外活性:近期研究综述
J Antimicrob Chemother. 2004 Jun;53 Suppl 2:ii11-21. doi: 10.1093/jac/dkh204.
6
Antibacterial properties of traditionally used Indian medicinal plants.传统使用的印度药用植物的抗菌特性。
Methods Find Exp Clin Pharmacol. 2007 Mar;29(2):79-92. doi: 10.1358/mf.2007.29.2.1075347.
7
[Characteristics of war wound infection].[战伤感染的特点]
Acta Med Croatica. 2006 Sep;60(4):353-63.
8
[The etiological structure of the causative agents of inflammatory nonspecific urological diseases and the dynamics of their resistance to the widely used antibiotics].
Urol Nefrol (Mosk). 1997 May-Jun(3):13-8.
9
In vitro activity of 11 antibiotics against 74 anaerobes isolated from pediatric intra-abdominal infections.11种抗生素对从儿童腹腔内感染分离出的74株厌氧菌的体外活性。
Anaerobe. 2006 Apr;12(2):63-6. doi: 10.1016/j.anaerobe.2005.11.004. Epub 2005 Dec 27.
10
In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.头孢洛林(PPI-0903M,T-91825)对具有明确耐药机制和表型的细菌的体外活性。
J Antimicrob Chemother. 2007 Aug;60(2):300-11. doi: 10.1093/jac/dkm150. Epub 2007 Jun 4.